Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer

被引:19
作者
Ferroni, Patrizia [1 ]
Riondino, Silvia [1 ]
Portarena, Ilaria [2 ]
Formica, Vincenzo [2 ]
La Farina, Francesca [1 ]
Martini, Francesca [1 ]
Massimiani, Gioia [2 ]
Palmirotta, Raffaele [1 ]
Guadagni, Fiorella [1 ]
Roselli, Mario [2 ]
机构
[1] IRCCS San Raffaele Pisana, Dept Lab Med & Adv Biotechnol, I-00163 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Internal Med, Tor Vergata Clin Ctr, Rome, Italy
关键词
Metastatic colorectal cancer; Activated protein C; Tumor necrosis factor alpha; Venous thromboembolism; VENOUS THROMBOEMBOLISM; CARCINOEMBRYONIC ANTIGEN; TNF-ALPHA; INFLAMMATION; THROMBOSIS; CYTOKINES; CHEMOTHERAPY; LEIDEN; BLOOD; RISK;
D O I
10.1007/s00384-012-1493-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose The purpose of this study was to investigate the possible association between tumor necrosis factor-alpha (TNF-alpha) levels and defects in the activated protein C (APC) system as a determinant of venous thromboembolism (VTE) in metastatic colorectal cancer patients (mCRC) undergoing chemotherapy. Methods TNF-alpha levels (measured by immunoassay) and abnormalities in the APC system [evaluated by an APC-dependent thrombin generation assay (ThromboPath-ThP)] were evaluated in 45 mCRC patients undergoing chemotherapy. VTE events were recorded during follow-up. Results TNF-alpha levels were increased (p < 0.01), and APC functionality was decreased (p < 0.0001) in mCRC patients compared to age- and sex-matched controls. An inverse correlation was observed between TNF-alpha and APC impairment in mCRC (p < 0.0001). TNF-alpha was confirmed as an independent predictor (p = 0.007) for APC abnormalities at multivariate regression analysis. Nine (20 %) of 45 mCRC patients experienced VTE during chemotherapy. Bayesian analysis of combined ThP/TNF-alpha showed a positive predictive value of 0.67 in predicting VTE (p = 0.01). Cox proportional hazards survival analysis confirmed the predictive value of combined ThP/TNF-alpha determination in VTE risk assessment of mCRC patients (either negative vs. both positive: HR = 0.02; p = 0.001), and Kaplan-Meier analysis demonstrated that mCRC patients with either negative TNF-alpha or ThP values prior to chemotherapy were less likely to experience VTE (13 %) than patients with abnormalities of both markers (67 %, p = 0.002). Conclusions These results suggest that the host inflammatory response to cancer cells and/or tumor-derived cytokines could be responsible for an impairment of the APC system and a switch toward a pro-thrombotic state, which might predispose to the occurrence of VTE in mCRC patients undergoing chemotherapy.
引用
收藏
页码:1561 / 1567
页数:7
相关论文
共 50 条
[41]   INCREASED TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN-6 SERUM LEVELS AND THEIR CORRELATION WITH LABORATORY PARAMETERS IN PATIENTS WITH IMPORTED MALARIA [J].
Poluga, Jasmina ;
Dopsaj, Violeta ;
Veljkovic, Milena ;
Maksic, N. ;
Stojakovic, Sonja ;
Dunjic, Radica ;
Dakic, Zorica ;
Pavlovic, Milorad .
ARCHIVES OF BIOLOGICAL SCIENCES, 2012, 64 (04) :1577-1583
[42]   Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome [J].
Sarac, F. ;
Basoglu, O. K. ;
Gunduz, C. ;
Bayrak, H. ;
Avci, C. Biray ;
Akcicek, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (07) :528-533
[43]   Association between Tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis [J].
Ma, Liping ;
Zhao, Jiangyang ;
Li, Taijie ;
He, Yu ;
Wang, Jian ;
Xie, Li ;
Qin, Xue ;
Li, Shan .
DIAGNOSTIC PATHOLOGY, 2014, 9
[44]   Increased interleukin 1 and tumor necrosis factor alpha levels after thyroid surgery [J].
Ozcinar, Beyza ;
Aksakal, Nihat ;
Yanar, Fatih ;
Agcaoglu, Orhan ;
Peker, Kivanc Derya ;
Turkoglu, Umit ;
Mercan, Selcuk ;
Ozarmagan, Selcuk ;
Erbil, Yesim .
TURKISH JOURNAL OF SURGERY, 2014, 30 (02) :80-84
[45]   Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism [J].
Elice, Francesca ;
Fink, Louis ;
Tricot, Guido ;
Barlogie, Bart ;
Zangari, Maurizio .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (04) :399-405
[46]   Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis [J].
Ward, M. P. ;
Ibrahim, E. M. ;
O'Toole, S. A. ;
Marchocki, Z. ;
O'Leary, J. J. ;
Abu Saadeh, F. ;
Norris, L. A. .
THROMBOSIS RESEARCH, 2025, 246
[47]   Tumor necrosis factor-alpha-308G/A single nucleotide polymorphism and red-complex periodontopathogens are independently associated with increased levels of tumor necrosis factor-α in diseased periodontal tissues [J].
Trombone, A. P. F. ;
Cardoso, C. R. ;
Repeke, C. E. ;
Ferreira, S. B., Jr. ;
Martins, W., Jr. ;
Campanelli, A. P. ;
Avila-Campos, M. J. ;
Trevilatto, P. C. ;
Silva, J. S. ;
Garlet, G. P. .
JOURNAL OF PERIODONTAL RESEARCH, 2009, 44 (05) :598-608
[48]   Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes [J].
Szulinska, M. ;
Piorunek, T. ;
Suliburska, J. ;
Pupek-Musialik, D. ;
Kupsz, J. ;
Drzymala-Czyz, S. ;
Bogdanski, P. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (14) :1916-1922
[49]   A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome [J].
Kume, T. ;
Calan, M. ;
Yilmaz, O. ;
Kocabas, G. U. ;
Yesil, P. ;
Temur, M. ;
Bicer, M. ;
Calan, O. G. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (07) :747-754
[50]   Tumor necrosis factor-alpha-308 gene promoter polymorphism associates with survival of cancer patients A meta-analysis [J].
Yi, Fengshuang ;
Shi, Xinyu ;
Pei, Xuebin ;
Wu, Xiuzhi .
MEDICINE, 2018, 97 (45)